About BeOne Medicines

BeOne Medicines builds groundbreaking oncology therapies that reach more people around the world than ever before. The company advances a broad and deep pipeline of cancer treatments through rigorous science and exceptional speed, covering blood, lung, breast, gastrointestinal, and rare cancers. Operating across six continents with over 12,000 employees, BeOne delivers transformative medicines to patients in 75+ countries. People with cancer deserve hope and better tomorrows. BeOne challenges the status quo by accelerating development timelines, fostering non-hierarchical collaboration, and ensuring that innovative treatments remain accessible. Every decision stems from a core value: patients first.